Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Linnerbauer

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 29, 2020
Protective Functions of Reactive Astrocytes Following Central Nervous System InsultMathias Linnerbauer, Veit Rothhammer
Cells|March 27, 2024
Gut-Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and BeyondJulia Zißler, Veit Rothhammer, Mathias Linnerbauer
Frontiers in Immunology|December 15, 2023
The role of midkine in health and diseaseEmely Elisa Neumaier, Veit Rothhammer, Mathias Linnerbauer
Neuron|September 8, 2020
Astrocyte Crosstalk in CNS InflammationMathias Linnerbauer, Michael A Wheeler, Francisco J Quintana
Epilepsia|February 4, 2026
SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment responseJohannes Lang, Mathias Linnerbauer, Jeanne Cuny, et al.
Frontiers in Immunology|January 20, 2022
Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS InflammationMathias Linnerbauer, Lena Lößlein, Daniel Farrenkopf, et al.
Nature Protocols|September 26, 2024
Droplet-based functional CRISPR screening of cell-cell interactions by SPEAC-seqCamilo Faust Akl, Mathias Linnerbauer, Zhaorong Li, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple SclerosisAna Cirac, Thanos Tsaktanis, Tobias Beyer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MSThanos Tsaktanis, Tobias Beyer, Lucy Nirschl, et al.
JCI Insight|April 8, 2022
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammationMathias Linnerbauer, Lena Lößlein, Oliver Vandrey, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 29, 2020
Protective Functions of Reactive Astrocytes Following Central Nervous System InsultMathias Linnerbauer, Veit Rothhammer
Cells|March 27, 2024
Gut-Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and BeyondJulia Zißler, Veit Rothhammer, Mathias Linnerbauer
Frontiers in Immunology|December 15, 2023
The role of midkine in health and diseaseEmely Elisa Neumaier, Veit Rothhammer, Mathias Linnerbauer
Neuron|September 8, 2020
Astrocyte Crosstalk in CNS InflammationMathias Linnerbauer, Michael A Wheeler, Francisco J Quintana
Epilepsia|February 4, 2026
SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment responseJohannes Lang, Mathias Linnerbauer, Jeanne Cuny, et al.
Frontiers in Immunology|January 20, 2022
Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS InflammationMathias Linnerbauer, Lena Lößlein, Daniel Farrenkopf, et al.
Nature Protocols|September 26, 2024
Droplet-based functional CRISPR screening of cell-cell interactions by SPEAC-seqCamilo Faust Akl, Mathias Linnerbauer, Zhaorong Li, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 24, 2021
The Aryl Hydrocarbon Receptor-Dependent TGF-α/VEGF-B Ratio Correlates With Disease Subtype and Prognosis in Multiple SclerosisAna Cirac, Thanos Tsaktanis, Tobias Beyer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 28, 2020
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With Disease Activity in Progressive MSThanos Tsaktanis, Tobias Beyer, Lucy Nirschl, et al.
JCI Insight|April 8, 2022
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammationMathias Linnerbauer, Lena Lößlein, Oliver Vandrey, et al.
Pageof 3